Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146510
Max Phase: Preclinical
Molecular Formula: C24H35ClN4O2S2
Molecular Weight: 511.16
Molecule Type: Small molecule
Associated Items:
ID: ALA2146510
Max Phase: Preclinical
Molecular Formula: C24H35ClN4O2S2
Molecular Weight: 511.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN(CC[C@H]1CC[C@H](NS(=O)(=O)c2ccc(Cl)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
Standard InChI: InChI=1S/C24H35ClN4O2S2/c1-2-14-29(20-9-12-22-23(16-20)32-24(26)27-22)15-13-17-3-7-19(8-4-17)28-33(30,31)21-10-5-18(25)6-11-21/h5-6,10-11,17,19-20,28H,2-4,7-9,12-16H2,1H3,(H2,26,27)/t17-,19-,20-/m0/s1
Standard InChI Key: NIWDWBQBYKYOEX-IHPCNDPISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 511.16 | Molecular Weight (Monoisotopic): 510.1890 | AlogP: 4.88 | #Rotatable Bonds: 9 |
Polar Surface Area: 88.32 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.58 | CX Basic pKa: 10.70 | CX LogP: 4.14 | CX LogD: 2.22 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.50 | Np Likeness Score: -1.66 |
1. Chen J, Levant B, Wang S.. (2012) High-affinity and selective dopamine D₃ receptor full agonists., 22 (17): [PMID:22871578] [10.1016/j.bmcl.2012.07.003] |
Source(1):